How does the Form 4 describe the pricing of Globe Life (GL) share sales?

The Form 4 notes sales at prices ranging from $145.00 to $145.275 per share. It states that the reporting person will provide full information on the number of shares sold at each separate price upon request by SEC staff, the issuer, or any security holder.

Globe Life CEO exercises options, sells shares

Globe Life Inc. Co-Chairman & CEO James Matthew Darden exercised employee stock options for 18,318 shares and received an equal number of common shares at $100.74 each.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Globe Life Inc. Co-Chairman & CEO James Matthew Darden exercised employee stock options for 18,318 shares and received an equal number of common shares at $100.74 each. He then sold 18,318 common shares at an average of $145.1029 and made bona fide gifts totaling 7,358 shares, leaving 51,093.4598 shares held directly plus additional indirect holdings.

Insider Trade Summary

Exercise and Sale: 18,318 shares ($813K approx. pre-tax spread)

Exercise and Sale 6 txns

Insider Darden James Matthew

Role Co-Chairman & CEO

Sold 18,318 shs ($2.66M)

Approx. gross sale proceeds $2.66M

Approx. exercise cost $1.85M

Approx. pre-tax spread $813K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy)	18,318	$0.00	$0.00
Exercise	Common Stock	18,318	$100.74	$1.85M
Sale	Common Stock	18,318	$145.1029	$2.66M
Gift	Common Stock	7,358	$0.00	$0.00
Gift	Common Stock	7,358	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 26,682 contracts (Direct); Common Stock — 7,358 shares (Indirect, By Trust); Common Stock — 51,093.4598 shares (Direct); Common Stock — 4,185.585 shares (Indirect, 401(k) Plan)

Footnotes (2)

F1. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
F2. Sales at prices ranging from $145.00 per share to $145.275 per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Globe Life (GL) report for CEO James Matthew Darden?

James Matthew Darden exercised options for 18,318 shares, acquired the same number of Globe Life common shares at $100.74, then sold 18,318 shares at an average $145.1029. He also made bona fide gifts totaling 7,358 shares between direct and trust accounts.

How many Globe Life (GL) shares did the CEO sell in this Form 4?

The CEO sold 18,318 Globe Life common shares in an open-market or private transaction. The reported average sale price was $145.1029 per share, with detailed price breakdowns available on request, covering a range from $145.00 to $145.275 per share.

What option exercise did Globe Life (GL) disclose for its CEO?

Globe Life disclosed that its CEO exercised employee stock options covering 18,318 shares. The derivative exercise generated 18,318 common shares at a price of $100.74 per share, converting the option position into directly held Globe Life common stock holdings.

Were any Globe Life (GL) shares transferred as gifts in this filing?

Yes. The filing shows bona fide gifts of 7,358 Globe Life common shares. These gifts involved a reduction in directly held shares and a corresponding 7,358-share position held indirectly by a trust, both reported as gift transfers with a zero dollar per-share value.

What are James Matthew Darden’s Globe Life (GL) holdings after these transactions?

After the reported transactions, James Matthew Darden directly owns 51,093.4598 Globe Life common shares. He also has indirect holdings, including 7,358 shares held by a trust and 4,185.585 shares reported in a 401(k) plan position as of the stated dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/04/2026 - 05:27 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Darden James Matthew

(Last)

(First)

(Middle)

GLOBE LIFE INC.

7677 HENNEMAN WAY

(Street)

MCKINNEY

75070

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
GLOBE LIFE INC. [ GL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Co-Chairman & CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/02/2026		G		7,358	D	$0	51,093.4598	D
Common Stock	03/02/2026		G		7,358	A	$0	7,358	I	By Trust
Common Stock	03/04/2026		M		18,318	A	$100.74	69,411.4598	D
Common Stock	03/04/2026		S		18,318	D	$145.1029⁽¹⁾⁽²⁾	51,093.4598	D
Common Stock								4,185.585	I	401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$100.74	03/04/2026		M			18,318	02/26/2023	02/26/2027	Common Stock	18,318	$0	26,682	D

Explanation of Responses:

1. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

2. Sales at prices ranging from $145.00 per share to $145.275 per share.

	J. Matthew Darden by /s/ Chris T. Moore, Attorney- in-Fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR